Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1994 Oct;152(4):1108-10.
doi: 10.1016/s0022-5347(17)32515-6.

Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction

Affiliations
Clinical Trial

Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction

P Schramek et al. J Urol. 1994 Oct.

Abstract

Despite the availability of prostaglandin E1 for more than 7 years as a diagnostic and therapeutic tool in patients with erectile dysfunction, the problem of penile discomfort after prostaglandin E1 application has remained unsolved. In a randomized, double-blind, crossover study we investigated the effect of 2 different prostaglandin E1-procaine concentrations on 24 patients suffering from pain following intracorporeal injection of prostaglandin E1 alone. Intracavernous injection of 20 micrograms. prostaglandin E1 with 10 mg. procaine (study 1) failed to improve local painful sensations. The combination of 20 micrograms. prostaglandin E1 with 20 mg. procaine (study 2) decreased the incidence of local pain significantly (p < 0.01). These preliminary results show that the combination of prostaglandin E1 plus procaine represents a beneficial alternative in patients with penile pain due to the single substance.

PubMed Disclaimer

Comment in

  • Impotence.
    Goldstein I. Goldstein I. J Urol. 1994 Oct;152(4):1119-20. doi: 10.1016/s0022-5347(17)32518-1. J Urol. 1994. PMID: 8072078 No abstract available.

Publication types